Crop Life Science Ltd (CLSL) — shareholding pattern, promoter holding, financials and share price
About Crop Life Science Ltd (CLSL)
Crop Life Science Ltd operates in the Industrial Products industry, within the Capital Goods sector. It trades on the NSE as CLSL and on the BSE under scrip code 79036. Its ISIN is INE00NH01017.
Incorporated in 2006, Crop Life Sciences Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations [1]
Crop Life Science Limited is a leading Indian manufacturer of agro chemical formulations, including fungicides, herbicides, insecticides, and plant growth regulators. The company operates a manufacturing facility at GIDC Ankleshwar, Gujarat.
Since its inception, Crop Life Science has expanded its product range significantly and started exporting pesticides to countries like Indonesia, Bangladesh, and Egypt. It now offers over 85 agro chemical products.
Listed peers in Industrial Products: T & I Global Ltd, Ameya Precision Engineers Ltd, Mangalam Alloys Ltd, Maestros Electronics & Telecommun. Systems Ltd, BEW Engineering Ltd, Atam Valves Ltd.
Valuation & Returns
10 Jul 2026At ₹47.4 a share on 10 Jul 2026, Crop Life Science Ltd (CLSL) was valued at a price-to-earnings ratio of 12.31x against an industry P/E of 48.01x and a price-to-book of 0.96x on a book value of ₹49.15 per share. Solomo computes return on equity of 7.88% and return on capital employed of 10.42% from filed results.
- P/E
- 12.31x
- Industry P/E
- 48.01x
- P/B
- 0.96x
- EPS (TTM)
- ₹3.85
- Book value / share
- ₹49.15
- ROE
- 7.88%
- ROCE
- 10.42%
- ROA
- 3.12%
- Debt / equity
- 0.67x
- Dividend yield
- 0%
- EBITDA margin
- 9.47%
- 52-week range
- ₹39.05 – ₹62.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Crop Life Science Ltd (CLSL) reported revenue of ₹207 crore, net profit of ₹6 crore and earnings per share of ₹3.87. That compares with revenue of ₹196 crore and net profit of ₹6 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹87 crore and net profit ₹4 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 130 | 191 | 196 | 207 |
| Net profit (₹ cr) | 4 | 6 | 6 | 6 |
| EPS (₹) | 3.39 | 3.51 | 3.44 | 3.87 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 8.22% | 25.28% | 1.00% |
| Profit growth | 15.43% | 33.00% | -6.98% |
| Stock price CAGR | - | - | 17% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 70.01% of Crop Life Science Ltd (CLSL). Market capitalisation was ₹81 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Mar 2026: TEJAL PARAG DATTANI 4.03%, A1 MANAGEMENT AND CONSULTANCY 1.73%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 70.01% | - | - | - | - |
| Sep 2025 | 70.01% | - | - | - | - |
| Mar 2025 | 70.01% | - | - | - | - |
| Sep 2024 | 70.01% | - | - | - | - |
| Mar 2024 | 70.01% | - | - | - | - |
| Sep 2023 | 70.01% | - | - | - | - |